Both in Biotechnology
Revolution Medicines vs Exelixis
Over the past year RVMD returned +241.0% and EXEL returned +92.0%; their daily moves had a correlation of 0.29.
RVMD +241.0% EXEL +92.0%Growth of $1, one year, split-adjusted
| Metric | RVMD | EXEL |
|---|---|---|
| Price | $199.70 | $72.75 |
| Market cap | $42.80B | $17.75B |
| Today | +2.82% | +0.61% |
| 1 month | −0.1% | +24.7% |
| 6 months | +32.2% | +49.4% |
| Year to date | +150.7% | +66.0% |
| 1 year | +236.6% | +91.1% |
| Revenue growth (YoY) | — | +10.2% |
| Gross margin | — | 96.0% |
| Net margin | — | 33.1% |
| P/E (TTM) | — | 20.1× |
| Price / sales | — | 7.1× |
| Net cash | $3.45B | $892.0M |
| Dividend yield | — | — |
| Volatility (60d) | 39.9% | 25.7% |
| Short % of float | 6.4% | 11.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).